NK
Narendra Kumar
About Narendra Kumar
Data last updated:
Narendra Kumar is a Director at Sarcoma Remedies Private Limited (since 2015), Director at Meviraise Healthcare Private Limited (since 2020) and Designated Partner at Rishi Rajan Healthcare Llp (since 2025). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹4.57 Cr; the largest is Sarcoma Remedies Private Limited at ₹3.65 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sarcoma Remedies Private Limited U24239CH2015PTC035704 | Director | 21 Aug 2015 | 2015 | ₹3.65 Cr (FY 2025) | Active |
 Meviraise Healthcare Private Limited U85100UP2020PTC128428 | Director | 25 Apr 2020 | 2020 | ₹91.4 Lakh (FY 2024) | Active |
| Rishi Rajan Healthcare Llp ACS-2615 | Designated Partner | 27 Oct 2025 | 2025 | Active |
Board colleagues of Narendra Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ankit Kumar | 09067013 | Sarcoma Remedies Private Limited | Director |
| Swarn Singh | 02823071 | Sarcoma Remedies Private Limited | Director |
| Siddharth Singh | 08737275 | Meviraise Healthcare Private Limited | Director |
| Anurag Singh | 03542195 | Rishi Rajan Healthcare Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narendra Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narendra Kumar
Narendra Kumar currently holds 3 directorships: Sarcoma Remedies Private Limited (Director, since 21 Aug 2015, revenue ₹3.65 Cr (FY 2025)); Meviraise Healthcare Private Limited (Director, since 25 Apr 2020, revenue ₹91.4 Lakh (FY 2024)); Rishi Rajan Healthcare Llp (Designated Partner, since 27 Oct 2025).
Narendra Kumar was first appointed on 21 Aug 2015 as Director at Sarcoma Remedies Private Limited. The most recent appointment on record is 27 Oct 2025 at Rishi Rajan Healthcare Llp.
The 2 current companies of Narendra Kumar that report revenue have a combined latest revenue of ₹4.57 Cr: Sarcoma Remedies Private Limited ₹3.65 Cr (FY 2025); Meviraise Healthcare Private Limited ₹91.4 Lakh (FY 2024).
The current boards of Narendra Kumar's companies include Ankit Kumar (Sarcoma Remedies Private Limited), Swarn Singh (Sarcoma Remedies Private Limited), Siddharth Singh (Meviraise Healthcare Private Limited), Anurag Singh (Rishi Rajan Healthcare Llp).